Latest Breaking News On - தேசிய நிறுவனம் ஆன் - Page 25 : comparemela.com

Arizona PBS PHOENIX – For the first time since 2003, the Federal Drug Administration has approved a new treatment for Alzheimer’s disease, a progressive brain disorder that affects roughly 6 million people in the United States and is projected to affect more than 13 million by 2050. Last year, there were at least 42,000 more deaths from Alzheimer’s disease and other dementias in the U.S. – a 16% increase over the average of the preceding five years, according to an analysis of federal data by the Alzheimer’s Association. The new drug, Aduhelm, is given intravenously once a month. It wasn’t designed to be a cure, but rather aims to reduce brain damage and preserve cognitive function.

United statesKinsey mcmanusTodd levineHanna burkeAlzheimer association desert southwest chapterJohns hopkins universityBarrow neurological instituteNational institute onDrug administrationAlzheimer associationFederal drug administrationNational instituteDesert southwest chapterஒன்றுபட்டது மாநிலங்களில்கிந்ஸீ மக்ம்யாநஸ்டாட் லெவின்